• No results found

[PDF] Top 20 Efficacy and tolerability of atorvastatin as add on therapy in the treatment of chronic stable (moderate-severe) asthma for a duration of 8 weeks

Has 10000 "Efficacy and tolerability of atorvastatin as add on therapy in the treatment of chronic stable (moderate-severe) asthma for a duration of 8 weeks" found on our website. Below are the top 20 most common "Efficacy and tolerability of atorvastatin as add on therapy in the treatment of chronic stable (moderate-severe) asthma for a duration of 8 weeks".

Efficacy and tolerability of atorvastatin as add on therapy in the treatment of chronic stable (moderate-severe) asthma for a duration of 8 weeks

Efficacy and tolerability of atorvastatin as add on therapy in the treatment of chronic stable (moderate-severe) asthma for a duration of 8 weeks

... the treatment of various diseases like ...the efficacy and tolerability of atorvastatin as an add on therapy in the treatment of chronic stable asthma ... See full document

7

The Efficacy and Tolerability of Electrolyzed Oxidized Water in Treating Mild to Moderate Acne

The Efficacy and Tolerability of Electrolyzed Oxidized Water in Treating Mild to Moderate Acne

... EOW treatment include: a relatively short duration of therapy (8 weeks), good patient compliance, and lack of antibiotic ...the efficacy and tolerability of the EOW device ... See full document

11

Efficacy and safety of ivabradine as an add-on to atenolol in patients with chronic stable ischemic heart disease

Efficacy and safety of ivabradine as an add-on to atenolol in patients with chronic stable ischemic heart disease

... the duration of diastole during which most myocardial perfusion ...medical therapy for IHD, it is necessary to combine agents from different classes and titrate the doses as guided by the individual profile ... See full document

6

Efficacy and safety of formoterol versus montelukast as add on therapy in moderate persistent asthma

Efficacy and safety of formoterol versus montelukast as add on therapy in moderate persistent asthma

... improving asthma control and airway functions when inhaled corticosteroids alone are ...combination therapy is the preferred treatment when a standard dose of inhaled glucocorticosteroid alone fails ... See full document

6

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma

... with severe eosinophilic asthma experience frequent exacerbations and reduced lung function leading to poor health-related quality of ...for add-on maintenance therapy in patients with ... See full document

5

Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma

Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma

... words: Asthma, roflumilast, montelukast, phosphodiesterase 4 inhibitors The recent American Thoracic Society (ATS)/European Respiratory Society (ERS) Task Force on Severe Asthma has defined ... See full document

16

<p>Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis</p>

<p>Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis</p>

... indications. At the moment, it represents an effective biologic agent for the treatment of moderate to severe RA. As it lacks a head-to-head comparison with tocilizumab we cannot be directly sure ... See full document

7

Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence

Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence

... with moderate to severe persistent asthma is essential to reduce the significant morbidity associated with the ...similar efficacy and tolerability based on a recent meta-analysis of ... See full document

10

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis

... biologic therapy (54%). Moreover, clinical efficacy of apremilast was maintained over 52 weeks with continued ...intermittent treatment, as most patients who lost PASI 75 response after ... See full document

8

Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma

Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma

... treating asthma, until now disease- modifying efficacy has not been demonstrated for any of the existing drugs, therefore there is an essential need to develop new drugs that might be of additional benefit ... See full document

6

Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain

Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain

... and efficacy of this hydrocodone ER formulation developed with the CIMA ADT platform merits further study, and the findings from this study provide several important consider- ations for the design of future ... See full document

14

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis

... Takanori Numata 1* , Katsutoshi Nakayama 1,2 , Hirofumi Utsumi 1 , Kenji Kobayashi 1 , Haruhiko Yanagisawa 1 , Mitsuo Hashimoto 1 , Shunsuke Minagawa 1 , Takeo Ishikawa 1 , Hiromichi Hara 1 , Jun Araya 1 and Kazuyoshi ... See full document

9

Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial

Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial

... 24 weeks of treatment. Other secondary efficacy end points included time to first episode of asthma worsening (prespecified as exacerbation) and time to first severe asthma ... See full document

18

Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox–Gastaut syndrome: An observational study

Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox–Gastaut syndrome: An observational study

... Thus, in this subgroup of patients, LAC could inhibit an epileptogenic focus and therefore, prevent seizures arise from it. Our study have some weaknesses that make difficult to extrapolate it to other scenarios, these ... See full document

7

Aspirin Sensitivity in Patients with Moderate to Severe Asthma

Aspirin Sensitivity in Patients with Moderate to Severe Asthma

... with moderate and severe asthma (excluding mild cases) and the high association of the nasal polyposis with chronic rhinosinusitis in patients attending our center (as a referral center for ... See full document

5

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

... Tiotropium add-on therapy delivered via the Respimat Soft Mist inhaler in paediatric patients The results of the first studies of tiotropium add-on therapy in paediatric patients with ... See full document

11

Tailored therapy for severe asthma

Tailored therapy for severe asthma

... with severe asthma or COPD have often a suboptimal symptom control due to inadequate ...best treatment for the individual patient, such as IgE for omalizumab or periostin for ... See full document

8

Efficacy of Anti-TNF Therapy for the Treatment of Patients with Moderate-to-Severe Inflammatory Bowel Disease; a First Iranian Report

Efficacy of Anti-TNF Therapy for the Treatment of Patients with Moderate-to-Severe Inflammatory Bowel Disease; a First Iranian Report

... Naghavi et al. estimated that in our country, the burden of GI diseases ranked 7 th among all other diseases at 2003. 5 The main goal of therapeutic options in IBD patients is to reduce the inflammation and symptoms of ... See full document

7

leukotriene‑receptor antagonists (montelukast)  as add‑on therapy to inhaled corticosteroids  (budesonide) in moderate persistent asthma

leukotriene‑receptor antagonists (montelukast) as add‑on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma

... the efficacy between long‑acting beta 2‑agonists and leukotriene receptor antagonists as add‑on therapy to inhaled corticosteroids in moderate persistent ...with asthma in the ... See full document

6

ARTICLE. Higher-Dose Intravenous Magnesium Therapy for Children With Moderate to Severe Acute Asthma

ARTICLE. Higher-Dose Intravenous Magnesium Therapy for Children With Moderate to Severe Acute Asthma

... for asthma in children and adults more than doubled from 1975 to ...acute asthma, emer- gency department visits and hospitalizations continue to account for the predominant proportion of health care costs ... See full document

5

Show all 10000 documents...